Bahamas STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Bahamas STEM News.

Press releases published on November 12, 2026

Nov. 12, 2026

ZenaTech’s ZenaDrone Signs MOU with Rattler Medical to Develop Drone-Based Battlefield Blood Delivery System

Indeterminate GlobeNewswire

Nov. 12, 2026

Avicanna Reports Positive Adjusted EBITDA for Q3 2026 and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 12, 2026

Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 12, 2026

Immuneering to Collaborate with Astellas on Clinical Studies of Investigational CLDN18.2 Programs in Combination with Atebimetinib for Pancreatic Cancer Patients

Indeterminate GlobeNewswire

Nov. 12, 2026

Vor Bio Expands Strategic Partnership with RemeGen, Adding Next Generation, Long-Acting RC298 to BAFF/APRIL Franchise

Indeterminate GlobeNewswire

Nov. 12, 2026

Drones Drive Strong ENVX Revenue Growth

Indeterminate GlobeNewswire

Nov. 12, 2026

MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth

Indeterminate GlobeNewswire

Nov. 12, 2026

Dyadic’s C1-Produced RSV and Malaria Antibodies Advance into Animal Studies Following Positive Independent Evaluations

Indeterminate GlobeNewswire

Nov. 12, 2026

Ascendis Pharma Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 12, 2026

Quantum X Labs Joins the Global Race by Publishing Updated Execution Roadmap for Building its Cold-Atom Quantum Computer, Targeting Fault-Tolerant Computing by 2030

Indeterminate GlobeNewswire

Nov. 12, 2026

Generate Biomedicines Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 12, 2026

Altimmune Announces Publication of IMPACT Phase 2b 48-Week Data in MASH in The Lancet Gastroenterology & Hepatology

Indeterminate GlobeNewswire

Nov. 12, 2026

NervGen Receives FDA Breakthrough Therapy Designation for NVG-291 in Chronic Spinal Cord Injury

Indeterminate GlobeNewswire

Nov. 12, 2026

Century Therapeutics Reports Third Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

Nov. 12, 2026

Alterity Therapeutics to Present at the Virtual Bell Potter Healthcare Conference

Indeterminate GlobeNewswire

Nov. 12, 2026

Lantronix and Latent AI Bring Persistent Target Tracking to Spotter for Group 1 UAS

Indeterminate GlobeNewswire

Nov. 12, 2026

ProQR Announces Third Quarter 2026 Operating and Financial Results

Indeterminate GlobeNewswire

Nov. 12, 2026

Octave Announces Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 12, 2026

AAVantgarde to present progress toward the first treatment for Usher syndrome type 1B at EYENOVATE and FLORetina 2026

Indeterminate GlobeNewswire

Nov. 12, 2026

Can Health Systems Use Microsoft 365 Copilot With Patient Data? Start With Who Can Open the Records

Indeterminate GlobeNewswire